choline

Choline is a water-soluble essential nutrient that plays multiple critical roles in human biology. Chemically, choline is a quaternary ammonium compound (trimethylaminoethanol) that serves as the precursor to several biologically important molecules, including the neurotransmitter acetylcholine as well as phospholipids such as phosphatidylcholine and sphingomyelin that form structural components of cell membranes. These compounds are essential for cell membrane integrity, cellular signaling, lipid transport, and methyl group metabolism. Although the human liver can synthesize small amounts of choline through phosphatidylethanolamine methylation pathways, this endogenous production does not meet physiologic needs, making dietary intake necessary for health and survival. Dietary choline exists in foods in both free choline and esterified forms and is coupled with other nutrients such as betaine, which itself participates in methylation reactions. Historically, choline was considered part of the B vitamin complex (sometimes referred to as vitamin B4), but it is no longer classified as a vitamin because it can be synthesized endogenously. Nonetheless, the landmark Dietary Reference Intakes report by the U.S. Food and Nutrition Board established Adequate Intakes (AIs) for choline in 1998 after observing liver dysfunction in humans with very low choline intake. The criteria for setting these values focused on preventing hepatic damage as assessed by serum alanine aminotransferase elevation. Choline is also essential as a methyl donor, participating in one-carbon metabolism and homocysteine regulation via its oxidation to betaine. Its role in acetylcholine synthesis makes it important for neuromuscular transmission, memory, and cognitive functions. Populations with inadequate intake or increased requirements—such as pregnant and lactating individuals, those with certain genetic polymorphisms affecting choline metabolism, and people on total parenteral nutrition—are particularly dependent on dietary choline to avoid health consequences.

Choline’s functions in the human body are extensive and vital. First and foremost, choline is the essential precursor to acetylcholine, a neurotransmitter involved in memory, muscle control, mood regulation, and autonomic nervous system signaling. Without adequate choline, acetylcholine synthesis in cholinergic neurons is impaired, compromising neuromuscular and cognitive functions. Choline-derived acetylcholine also supports motor function and continuous nerve signal transmission. Beyond neurotransmission, choline is indispensable for the structural integrity of cell membranes. Its metabolites, phosphatidylcholine and sphingomyelin, are major phospholipids composing cellular membranes and lipoproteins. Phosphatidylcholine is especially critical for hepatic very-low-density lipoprotein (VLDL) formation and secretion, facilitating lipid export from the liver. Without adequate choline, lipid accumulation within hepatocytes can occur, increasing the risk for nonalcoholic fatty liver disease (NAFLD). Choline also participates in methyl group metabolism by conversion into betaine, a methyl donor in the remethylation of homocysteine to methionine, impacting cardiovascular and metabolic processes. Emerging research further highlights choline’s role across life stages. In pregnancy, choline supports fetal brain development, neural tube closure, and epigenetic regulation of gene expression. Systematic reviews indicate that higher maternal choline intake may lower the risk of adverse pregnancy outcomes and support cognitive development, yet a majority of pregnant women do not meet the recommended intake. Observational studies have also associated moderate dietary choline intake with reduced cardiovascular risk and improved liver biomarkers, although causality remains under investigation. Experimental models suggest that choline deficiency leads to muscle damage and hepatic dysfunction, reinforcing its essentiality. Cumulative evidence supports choline’s broad influence on health including cognitive aging, liver function, metabolic regulation, and cellular maintenance.

Dietary Reference Intakes for choline are expressed as Adequate Intakes (AIs), established when evidence is insufficient to derive a formal Recommended Dietary Allowance (RDA). Current AI values vary by age, sex, and physiologic state. For infants 0–6 months, the AI is 125 mg/day, reflecting choline content in human milk. From 7–12 months, the AI remains 125 mg/day. Children aged 1–3 years require 200 mg/day, those 4–8 years need 250 mg/day, and older children 9–13 years have an AI of 375 mg/day. During adolescence (14–18 years), males require 550 mg/day and females 400 mg/day. Adult males should aim for 550 mg/day, while adult females require 425 mg/day. Pregnancy increases choline needs to an AI of 450 mg/day, and lactation further increases needs to 550 mg/day. These values are designed to prevent liver dysfunction and support physiologic functions, not just minimal survival. Multiple factors influence individual choline requirements, including genetic polymorphisms in enzymes involved in choline biosynthesis and utilization. For example, variations in the PEMT gene can increase dietary choline requirements, especially in postmenopausal women. Hormonal status also affects endogenous synthesis; estrogen stimulates PEMT activity, potentially lowering dietary needs in premenopausal women. Diet composition including folate, vitamin B12, and methionine can alter choline demand due to shared roles in methyl metabolism. Despite these nuanced determinants, population intake assessments show that most people in the United States consume less than the AI, particularly women, which could contribute to suboptimal health outcomes. Consequently, health professionals often emphasize choline-rich dietary patterns to ensure adequate intake for diverse populations.

Signs of choline deficiency manifest primarily in liver and muscle dysfunction due to impaired membrane integrity and lipid transport. Clinical features include elevated serum alanine aminotransferase, hepatosteatosis (fatty liver), muscle damage with creatine kinase elevation, and in severe cases, liver fibrosis. Individuals receiving total parenteral nutrition lacking choline rapidly develop fatty liver and liver enzyme abnormalities, underscoring choline’s necessity for hepatic lipid export. Subclinical deficiency may present with fatigue, cognitive fog, and subtle neuromuscular symptoms due to compromised acetylcholine synthesis. Although frank choline deficiency is rare in healthy individuals, it is more prevalent in specific at-risk groups. A significant percentage of pregnant women fail to achieve the AI, placing them at higher risk for deficiency-related effects such as compromised fetal development and adverse pregnancy outcomes. Genetic variants affecting choline metabolism, such as polymorphisms in PEMT or MTHFD1, increase susceptibility to deficiency and may require higher dietary intake to maintain normal function. Additionally, individuals with diets low in choline—such as strict vegetarians or vegans without adequate plant-based choline sources—may have suboptimal choline status. Alcoholics and people with diseases affecting fat absorption or liver function may also be at higher risk. Routine blood tests for choline status are not widely standardized, but plasma choline measurements and biomarkers of liver function (ALT, AST) can help identify deficiencies. Optimal plasma choline reference ranges are not universally defined, but values significantly below population norms alongside liver dysfunction warrant clinical attention. Early identification and diet modification remain central to preventing the progression of deficiency-related disease.

Choline is abundant in a wide range of foods, with both animal and plant sources contributing to intake. Organ meats such as beef liver are among the richest sources; a 3-ounce cooked serving provides approximately 356 mg of choline, exceeding half of the adult daily value. Egg yolks are also particularly choline-rich, with one large hard-boiled egg providing around 147 mg. Other meats including beef, pork, and chicken breast provide moderate amounts of choline, making them valuable components of a choline-rich dietary pattern. Fish such as Atlantic cod and tuna also contribute choline along with protein and omega-3 fatty acids. Dairy products—milk and yogurt—contain smaller but meaningful choline amounts that can contribute to total daily intake. Plant-based sources, while generally lower in choline compared to animal products, still provide important contributions, especially for vegetarians and vegans. Soybeans and roasted soy products like tofu offer substantial choline content, as do quinoa, wheat germ, and cooked beans such as kidney or black beans. Cruciferous vegetables including broccoli, cauliflower, and Brussels sprouts contain choline in smaller amounts but contribute when consumed in larger servings. Seeds and nuts such as sunflower seeds and peanuts also add choline along with beneficial fats and micronutrients. Even whole grains like brown rice contain measurable choline. Combining these diverse food sources within meals helps ensure adequate intake across dietary patterns. Understanding food-based choline content supports dietary planning. For example, a meal combining eggs, lean meat, and legumes can significantly elevate total choline intake, helping individuals approach or meet their daily recommended levels. Plant‑forward diets can achieve adequate choline when rich sources like soy and legumes are emphasized. For people with higher choline requirements—such as pregnant individuals—focusing on both quantity and variety of choline-containing foods becomes even more critical. Taste preferences, cultural practices, and food accessibility influence individual patterns, but mindful inclusion of choline‑dense foods ensures a robust nutritional approach.

Dietary choline absorption occurs primarily in the small intestine, where both free choline and certain choline esters are taken up via transporter proteins. Esterified forms like phosphatidylcholine and sphingomyelin are digested by pancreatic and mucosal enzymes, releasing free choline for absorption. After absorption, choline enters the portal circulation, is taken up by the liver, and redistributed to tissues where it contributes to acetylcholine synthesis, membrane phospholipid formation, and methyl group metabolism. Some forms of choline incorporated into lipoproteins enter the lymphatic circulation prior to systemic distribution. Bioavailability varies by food matrix and choline form. Phosphatidylcholine, abundant in egg yolks and organ meats, appears highly bioavailable due to efficient enzymatic processing. Plant-based choline sources, while less concentrated, are still absorbed effectively, with overall intake quantity influencing net choline status more than minor differences in absorption efficiency. Dietary components affecting fat digestion—such as bile acid availability and pancreatic enzyme activity—can influence liberation of choline from esterified forms. Inhibitors of choline absorption are not well defined, but gastrointestinal disorders that impair fat digestion may reduce choline availability from complex forms. Conversely, co‑ingestion of adequate fat can enhance the emulsification and enzymatic breakdown of choline‑rich phospholipids, aiding absorption. Timing of intake appears less critical than consistent daily consumption of choline‑rich foods to maintain steady physiological levels. Genetic factors and gut microbiota composition can influence choline metabolism, including microbial conversion to trimethylamine (TMA), which affects systemic metabolite profiles and potentially health outcomes.

Choline supplements can help individuals who struggle to meet dietary intake recommendations through food alone. Because most people—including a high percentage of pregnant individuals—consume less than the Adequate Intake of choline, supplementation may be considered for at‑risk populations or those with specific health challenges. Supplements are available in various forms, including choline bitartrate, phosphatidylcholine, lecithin, and CDP‑choline. Each provides bioavailable choline, but comparative studies on relative absorption and clinical outcomes remain limited. Many multivitamins do not include significant choline, so dedicated choline supplements or combination products with B vitamins are often needed to achieve higher intake levels. When considering supplementation, factors such as dietary pattern, health status, and life stage are important. Pregnant and lactating individuals, whose choline needs are increased, may benefit from supplements to support maternal and fetal health, although choline is not universally included in standard prenatal formulations. People on strict vegetarian or vegan diets might also use supplements to ensure sufficient intake if plant‑based sources are not consumed in large amounts. Individuals with genetic variants that reduce endogenous choline synthesis may require higher intake levels to prevent deficiency. Supplements may be indicated for people with malabsorptive disorders or those on long‑term total parenteral nutrition that does not include choline. Healthcare professionals can guide appropriate dosing, balancing potential benefits against safety and tolerance. Generally, supplement doses range from 100–500 mg per serving, but higher amounts may be used under clinical supervision. Evidence for supplementation benefits includes improved liver lipid metabolism and cognitive markers in some studies, though research is ongoing and not conclusive for all health outcomes. Individualized assessment ensures that supplementation complements dietary intake without exceeding safe upper limits.

Although choline is essential, excessive intake—particularly from supplements—can cause adverse effects. The tolerable upper intake level (UL) for adults is set at 3,500 mg/day to minimize the risk of side effects. Intakes above this threshold have been associated with fishy body odor (due to trimethylamine production), excessive sweating, gastrointestinal distress such as nausea and diarrhea, hypotension, and potential liver toxicity. Trimethylamine N‑oxide (TMAO), a metabolite produced by gut microbial metabolism of excess choline, has been linked in observational studies to cardiovascular risk, although causal relationships remain unclear. Achieving these high doses solely through diet is unlikely; the primary risk arises from high‑dose supplements. Children have lower ULs based on age: approximately 1,000 mg/day for ages 1–8, 2,000 mg/day for ages 9–13, and 3,000 mg/day for ages 14–18. Exceeding these intakes increases the likelihood of cholinergic side effects and metabolic disturbances. Individuals with certain health conditions—such as liver or kidney impairment—may be more sensitive to high choline intake and should avoid excessive supplementation. Healthcare providers should evaluate total choline exposure from both diet and supplements when advising on safe upper limits. Balancing intake to achieve adequate but not excessive levels involves emphasizing food sources and limiting supplemental doses above the recommended Adequate Intakes unless clinically indicated. Monitoring for signs of excess and adjusting intake accordingly supports safe and effective choline nutrition.

Choline and choline‑containing compounds can interact with medications, potentially altering their effects. Specific interactions include combinations with anticholinergic drugs, cholinesterase inhibitors, and choline salicylate formulations. Choline salicylate, a topical analgesic form, has documented interactions with multiple drugs including alcohol, anticoagulants, and certain antibiotics, affecting efficacy and safety. Other interactions may involve increased serum choline concentrations when taken with medications such as bupropion or isavuconazole, but evidence is limited and primarily derived from case reports and theoretical mechanisms. Choline can also influence medications that affect cholinergic neurotransmission. For example, combining choline with drugs that increase acetylcholine levels or anticholinesterase agents could theoretically amplify cholinergic activity, potentially leading to side effects such as bradycardia or excessive salivation. Conversely, anticholinergic medications may blunt the effects of acetylcholine, impacting neuromuscular and cognitive processes. Individuals taking medications for neurologic conditions—such as Parkinson’s disease or Alzheimer’s disease—should consult healthcare professionals about possible interactions. Alcohol and high choline intake may interact metabolically, as both influence hepatic function and methyl metabolism. Given the complexity of drug‑nutrient interactions, individuals should discuss all supplements and medications with their clinician or pharmacist to identify potential interactions and optimize treatment outcomes.

Common Forms: Choline bitartrate, Phosphatidylcholine, Lecithin, CDP‑choline

Typical Doses: 100–500 mg per serving in supplements

When to Take: With meals to enhance absorption of phospholipid forms

Best Form: Phosphatidylcholine (rich in egg yolks and supplemental lecithin)

⚠️ Interactions: Anticholinergic medications, Cholinesterase inhibitors, Alcohol